Coverage of primary and booster vaccination against COVID-19 by socioeconomic level: A nationwide cross-sectional registry study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Coverage of primary and booster vaccination against COVID-19 by socioeconomic level: A nationwide cross-sectional registry study

Published:2023-01-02 Issue:1 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Hansen Bo T.¹²^ORCID,Labberton Angela S.³^ORCID,Kour Prabhjot⁴^ORCID,Kraft Kristian B.³^ORCID

Affiliation:

1. Department of Infection Control and Vaccine, Norwegian Institute of Public Health, Oslo, Norway

2. Department of Research, Cancer Registry of Norway, Oslo, Norway

3. Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway

4. Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway

Funder

funding agencies in the public, commercial

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2188857

Reference34 articles.

1. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

2. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

3. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

4. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study

5. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 vaccine uptake in a predominantly minoritized cohort hospitalized during the early pandemic in New York City;Vaccine;2024-12

2. Access to COVID-19 vaccination by socio-economic status in older Singaporean adults: a population-based cohort study;Public Health;2024-08

3. Sociodemographic Inequalities in COVID-19 Booster Dose Vaccination Coverage: a Retrospective Study of 196 Provinces in Peru;Journal of Racial and Ethnic Health Disparities;2024-06-24

4. Area and individual level analyses of demographic and socio-economic disparities in COVID-19 vaccination uptake in Belgium;Vaccine: X;2024-06

5. Coverage and predictors of COVID-19 vaccination in rural districts of Pakistan;Eastern Mediterranean Health Journal;2024-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3